Relationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: A pharmacoepidemiological study

European Journal of Clinical Pharmacology

Volumn 69, Issue 4, 2013, Pages 901-908

  Maison, Patrick ^a,b,c   Desamericq, Gaelle ^a,b,c   Hemery, François ^a   Elie, Nicole ^d   Del'Volgo, Aldo ^d   Dubois Randé, Jean Luc ^a,b,c   Hittinger, Luc ^a,b,c   Macquin Mavier, Isabelle ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

^d National Health Insurance Fund   (France)

Author keywords

Comparative effectiveness; Database; Drug utilization; Heart failure; Mortality; Pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; THIENOPYRIDINE DERIVATIVE;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; FRANCE; HEALTH INSURANCE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL TIME; TEACHING HOSPITAL;

AGED; CHRONIC DISEASE; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART FAILURE; HOSPITALS, TEACHING; HUMANS; MALE; MORTALITY; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINES AS TOPIC;

EID: 84876719623     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1400-9     Document Type: Article

References (34)

1. McMurray JJV, Pfeffer MA (2005) Heart failure. Lancet 365:1877-1889
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-989
3. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G (2000) A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J 21:763-769
4. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325:293-302
5. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316:1429-1435
6. The CIBIS Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9-13
7. The MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001-2007
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
9. Cowie MR (1999) Annotated references in epidemiology. Eur J Heart Fail 1:101-107
10. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJS, Poole-Wilson PA, Sutton GC (2002) Hospitalization of patients with heart failure: a population-based study. Eur Heart J 23:877-885
11. Davis RC, Hobbs FDR, Kenkre JE, Roalfe AK, Hare R, Lancashire RJ, Davies MK (2002) Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 325:1156
12. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC (2000) Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35:1628-1637
13. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM (2002) Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J 143:412-417
14. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS (2004) The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 140:714-720
15. Horwich TB, MacLellan WR, Fonarow GC (2004) Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 43:642-648
16. Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC (2011) Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). Am J Cardiol 107:1818-1823
17. Maison P, Cunin P, Hemery F, Fric F, Elie N, Del'volgo A, Dubois-Randé JL, Hittinger L, Macquin-Mavier I (2005) Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Eur J Clin Pharmacol 61:445-451
18. Dobre D, van Veldhuisen DJ, DeJongste MJL, van Sonderen E, Klungel OH, Sanderman R, Ranchor AV, Haaijer-Ruskamp FM (2007) The contribution of observational studies to the knowledge of drug effectiveness in heart failure. Br J Clin Pharmacol 64:406-414
19. Spreeuwenberg MD, Bartak A, Croon MA, Hagenaars JA, Busschbach JJV, Andrea H, Twisk J, Stijnen T (2010) The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health. Med Care 48:166-174
20. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Rydén L, Thygesen K, Uretsky BF (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100:2312-2318
21. Shah R, Wang Y, Foody JM (2008) Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients > or = 65 years of age with heart failure and preserved left ventricular systolic function. Am J Cardiol 101:217-222
22. Allen LaPointe NM, Zhou Y, Stafford JA, Hernandez AF, Kramer JM, Anstrom KJ (2009) Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease. Am J Cardiol 103:1518-1524
23. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355
24. Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JCM (2004) Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 25:1300-1309
25. Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215-225
26. Van der Harst P, Böhm M, van Gilst WH, van Veldhuisen DJ (2008) The case for statin therapy in chronic heart failure. Clin Res Cardiol 97:139-146
27. Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JGF, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJV, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248-2261
28. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G (2008) Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372:1231-1239
29. Tang WHW, Francis GS (2010) Statin treatment for patients with heart failure. Nat Rev Cardiol 7:249-255
30. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr (2001) ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104:2996-3007
31. Johnson D, Jin Y, Quan H, Cujec B (2003) Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 42:1438-1445
32. Nicol ED, Fittall B, Roughton M, Cleland JGF, Dargie H, Cowie MR (2008) NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart 94:172-177
33. Saczynski JS, Darling CE, Spencer FA, Lessard D, Gore JM, Goldberg RJ (2009) Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatr Soc 57:1587-1594
34. Teng T-HK, Hung J, Finn J (2010) The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia. Med J Aust 192:306-310